The influence of pre-radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers by D'Hondt, Eric et al.
.................... ................................................ 
GRADUATE RESEARCH/FEATURE ARTICLE 
Eric D’Hondt, Avraham Eisbruch, MD, Jonathan A. Ship, DMD 
The influence of pre-radiation salivary flow rates 
and radiation dose on parotid salivary gland dysfunction 
in patients receiving radiotherapy for head and neck cancers 
Radiotherapy (RT) used for head 
and neck cancers causes permanent 
salivary gland dysfunction (SGD). 
Previous short-term studies have 
demonstrated that pre-RT salivary 
flow rates and the amount of radia- 
tion exposure to parotid glands influ- 
ence the amount of RT-induced SGD. 
The purpose of this study was to 
determine which variables are rela- 
ted to the development of long-term 
post-RT SGD. Parotid flow rates 
(PFR) were assessed prior to and 1 
year after completion of RT in spared 
parotid glands from 34 patients from 
2 parotid-sparing protocols. The 
results reveal that spared PFR were 
not significantly higher 1 year post- 
RT in patients who had high pre-RT 
PFR, when compared with patients 
with low pre-RT PFR. However, 
patients who received higher doses 
of RT to spared parotid glands had 
lower PFR 1 year post-RT, compared 
with patients who had received 
lower doses of RT. These one-year 
findings suggest that high pre-RP 
PFR do not provide protection 
against RT-induced SGD. Conversely, 
reduced RT dosages to contralateral 
parotid glands are protective of PFR 
after completion of RT. 
This paper won second prize in the 8th 
Annual Saul Kamen Scientific Report 
Contest. 
n 1995, there were an estimated 
28,150 newly reported cases of 
oral and pharyngeal cancer in the 
United States, with an estimated 
8,370 deaths from these cancers1 
Incidence rates of oral pharyngeal 
cancer increase with age, with over 
95”/0 of all oral cancers occurring in 
individuals aged 45+ years2 Nearly 
70% of these cancers occur in persons 
older than age 65? The mortality 
rates for oral cancer also increase 
with age, and are high compared 
with other cancers, with an overall 
five-year survival rate of only 50Yi3 
Radiation therapy (RT) is a common- 
ly used method of treatment for 
patients with head and neck cancers 
(H&NC). The goal of RT is to eradi- 
cate the tumor without causing sig- 
nificant or permanent damage to the 
oral-pharyngeal tissues that are at 
low risk for cancer ~ p r e a d . ~  Currently, 
many of the RT techniques used in 
the treatment of H&NC have side- 
effects detrimental to the oral cavity, 
including the loss of salivary gland 
function and a persistent complaint 
of a dry mouth (xero~tornia).~ As a 
consequence, patients suffer from 
oral discomfort and mucositis, diffi- 
culty chewing and swallowing, taste 
changes, dental caries, oral microbial 
changes, and chronic esophagitis. 
Severe reduction of salivary gland 
output not only results in a rapid 
deterioration in oral health but also 
has a negative impact on the quality 
of a person’s life.6 Despite much 
research, there is still no effective 
treatment for radiation-induced sali- 
vary dysfunction (SGD).7 
There is great inter-individual 
variation in the amount of SGD pro- 
duced by RT.8 Our previous studies 
have demonstrated that, through the 
use of three-dimensional treatment 
planning (3-DTP), radiation doses to 
contralateral parotid glands can be 
minimized, thereby reducing the 
amount of SGD in patients receiving 
either unilateral neck or partial bilat- 
eral neck RT for H&NC.”’” Currently, 
it is difficult to predict the extent of 
RT-induced SGD in a patient receiv- 
ing radiation for H&NC. Previous 
studies have identified some vari- 
ables which may provide protection 
from RT-induced SGD. Two studies 
reported that patients with high pre- 
radiation salivary flow rates, inde- 
pendent of gland size, required larger 
doses of radiation to produce mini- 
mal flow rates.’*J3 Other investiga- 
tions have suggested that there is a 
dose-response relationship in parotid 
salivary flow rates in patients under- 
going RT for H&NC.12-14 In summa- 
ry, based upon previous reports, it 
appears that three variables influence 
the amount of RT-induced SGD: pre- 
radiation unstimulated flow rates, 
pre-radiation stimulated flow rates, 
and radiation dose. However, most of 
these results are from short-term 
studies (< 3 months) which did not 
follow patients to ascertain long-term 
(> 1 year) radiation changes. In addi- 
tion, the assessment of radiation dose 
in all of these studies was performed 
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by clinical estimation rather than by 
exact dosimetric methods. It is essen- 
tial to know what predictors there are 
for long-term RT-induced SGD, since 
other investigators have reported that 
permanent SGD occurs after head 
and neck RT.sJ2-'4 
The purpose of this investigation 
was to determine which variables are 
related to the development of SGD. If 
successful, results from this study 
could assist in predicting the salivary- 
related prognosis of a patient under- 
going RT for H&NC. It was hypothe- 
sized that patients with high pre- 
radiation parotid salivary flow rates 
would be more resistant to the delete- 
rious effects of RT, and thus would 
be less likely to develop RT-induced 
SGD up to 1 yr following completion 
of RT. It was also hypothesized that 
high RT doses to contralateral 
parotid glands would be associated 
with lower flow rates 1 yr post-RT. 
Materials and methods 
Subjects 
Thirty-four subjects were examined 
from 2 parotid-sparing protocols cur- 
rently under investigation at the 
University of Michigan (Table l).9-11 
Entrance criteria for patients includ- 
ed an histologically confirmed inva- 
sive cancer of the head and neck 
region (Table 2). Patients were exclu- 
ded from this analysis if they had a 
poorly controlled systemic disease 
requiring concomitant medical inter- 
vention. Patients taking medications 
were also excluded from this analysis 
if they experienced changes during 
the treatment and follow-up period 
in drugs which are known to affect 
salivary f~nct ion . '~  Twenty patients 
with unilateral H&NC where the risk 
for contralateral neck node involve- 
ment was considered low (< 15%) 
received ipsilateral neck radiationlo 
In 14 patients, where the tumor was 
more extensive and the risk for con- 
tralateral neck node involvement was 
considered high, bilateral neck radia- 
tion was used, while the contralateral 
parotid gland was at least partially 
spared RT.9,11 
Table 1. Subjects. 
Ipsilateral Protocol Bilateral Protocol p Value 
(n = 20) (n = 14) 
Age (yrs) (mean k SD) 60.6 i 2.5 55.1 2 3.5 2 0.05 
Age range 45 - 75 20 - 82 
Gender 11 males/9 females 11 males/3 females 
Table 2. Cancer diagnosis and TNM stage. 
Number of Subjects Total Subjects 
Tumor Type 
Squamous cell carcinoma 19 
Adenocystic carcinoma 4 
Mucoepidermoid carcinoma 5 
Neuroepithelial carcinoma 1 
Malignant schwannoma 1 
Large lymph cell carcinoma 1 
Neuroendocrine carcinoma 1 






































n = 34 
a TX = Unknown primary. 
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Table 3. Parotld salivary flow rates and radiation dose.= 
Ipsilateral Protocol (n = 20) Bilateral Protocol (n = 14) 
Spared Gland Treated Gland p Valuec Spared Gland Treated Gland p ValueC 
UPFR~ 
1 yr post-RT 0.06 & 0.08 0 0.0001 0.03 -c 0.06 0 0.002 
Baseline 0.07 f 0.06 0.04 f 0.05 NS 0.07 f 0.07 0.10 f 0.11 NS 
p valued NS 0.0003 0.03 0.007 
SPFR' 
Baseline 0.40 * 0.24 0.24 f 0.47 NS 0.38 f 0.21 0.37 f 0.30 NS 
1 yr Post-RT 0.46 f 0.59' 0 0.02 0.22 f 0.23 0 0.0009 
p value NS 0.001 0.03 0.0005 
Radiation dose 3.6 k 2.0' 51.5 t 14.6 0.0001 20.2 f 6.6 57.1 f 5.6 0.0001 
(GY) 
a Results expressed as mean f SD. 
Unstimulated parotid flow rate (mL/min). 
Spared vs. treated glands. 
Baseline vs. 1 yr post-RT. 
Stimulated parotid flow rate (mL/min). 
Ipsilateral spared vs. bilateral spared; p < 0.05. 
' ' 
3-D radiation treatment planning 
(SDTP) 
All patients underwent immobiliza- 
tion and full 3-DTP through the 
University of Michigan Radiation- 
Oncology planning system.16 3-DTP 
and conformal dose delivery consti- 
tute a new therapeutic modality that 
conforms high-dose radiation volume 
to the shape of a tumor while mini- 
mizing the dose to tissue that is not at 
risk for containing cancer. Target vol- 
umes include the primary tumor 
mass and lymph node areas which 
contain metastases, along with lymph 
node groups that are at risk for 
microscopic extension. Treatment 
volumes for H&NC and radiation 
dose to each parotid gland can be 
measured by the treatment planning 
computer program and cross-section- 
al CT images. 
sion of the contralateral par0 tid 
gland (in the case of a lateralized 
tumor) or the gland at the side of the 
neck least involved with the tumor 
(in the case of bilateral neck involve- 
ment) from the primary beam while 
providing adequate volume coverage 
to the targets. If this was not possible, 
The goal of 3-DTP was full exclu- 
3-DTP permitted the lowest dose pos- 
sible to be administered to the con- 
tralateral parotid gland. All patients 
were treated with continuous con- 
ventional fractionation, and received 
1.8-2.0 Gy fractions, 1 fraction per 
day, 5 fractions per week. All treat- 
ment was delivered with megavolt- 
age energies by the linear accelera- 
tion or racetrack microtron. 
Parotid salivary flow 
measurements 
Bilateral parotid saliva samples were 
collected prior to RT (baseline) and 12 
mos after the completion of RT. All 
salivary samples were collected 
between 8 a.m. and Noon to control 
for circadian variations in salivary 
gland function.17 Unstimulated paro- 
tid saliva (UPFR) was collected from 
both parotid gland orifices (Stensen's 
duct) with the use of a Carlson- 
Crittenden cup for 2 min as described 
previously.18 Salivary flow was stim- 
ulated (SPFR) by 2% citric acid 
swabbed on the dorso-lateral surfaces 
of the tongue at 30-second intervals 
for 2 min for equilibration. This was 
followed by a two-minute collection 
period during which gustatory stimu- 
lation was maintained. Following col- 
lection, the volumes of all saliva sam- 
ples were determined gravimetrically 
by means of an analytical balance, 
assuming a specific gravity of 1.0. 
Statistical analysis 
Paired tests were used for compar- 
isons of UPFR and SPFR between 
treated and spared glands for each 
collection period. Comparisons were 
also performed for UPFR and SPFR 
between baseline and one-year post- 
completion of RT for the treated and 
spared glands. A paired t test was 
used where mean values were 
assumed to have a normal distribu- 
tion, and a two-sample robust analy- 
sis was used where normality was 
not a plausible assumption.19 Direct 
comparisons (paired t tests) were 
used for the evaluation of differences 
in the amounts of radiation delivered 
to the spared and treated glands. 
The 3 variables investigated were: 
(1) baseline unstimulated parotid 
flow rates (UPFR) from spared 
glands, (2) baseline stimulated 
parotid flow rates (SPFR) from 
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spared glands, and (3) mean radia- 
tion dose to spared parotid glands. 
Patients in the ipsilateral and bilater- 
al radiation protocols were placed 
into separate groups. For the first 2 
variables at baseline, patients in each 
of the 2 radiation protocols were ana- 
lyzed separately by being divided 
into two subgroups: highest 1/2 and 
lowest 1'2 . For the third variable, 
patients in both protocols were com- 
bined, since there were unequal num- 
bers of subjects in the ipsilateral and 
bilateral groups. This analysis for 
radiation dose compared subjects in 
the highest 1/4 and lowest 1/4. Within 
each group, PFR at baseline and 1 yr 
post-RT were compared by paired t 
tests. One year post-radiation spared 
UPFR and SPPR were compared by 
Student's f tests between the highest 
1/2 and lowest 1/2 group for each of 
the first two variables, and between 
the highest 1/4 and lowest 1/4 group 
for the third variable. A criterion of p 
< 0.05 was accepted for significance 
in all statistical tests. 
Results 
This paper describes the results from 
34 subjects in two parotid-sparing 
protocols treated with the use of 3- 
DTP. Patients in both the ipsilateral 
(p = 0.0001) and bilateral (p = 0.0001) 
protocols received significantly 
greater radiation to treated parotid 
glands compared with spared glands 
(Table 3). On average, radiation expo- 
sure to the spared gland was less 
than one-tenth (ipsilateral protocol) 
and almost one-third (bilateral proto- 
col) the total amount of radiation 
delivered to the treated glands. 
During the one-year period following 
RT, there were no cases of cancer 
recurrence in all 34 patients in the 
regions spared radiotherapy. 
spared glands at baseline and 1 yr 
post-RT are shown in Table 3. For 
patients in both the ipsilateral and 
bilateral protocols, UPFR and SPFR 
in the treated glands were significant- 
ly lower 1 yr after the completion of 
RT compared with baseline. One year 
post-RT UPFR from spared glands in 
patients in the ipsilateral protocol 
UPFR and SPFR from treated and 
Fig 1. Unstimulated parotid flow rates (UPFR) at baseline (pre-RT) and 1 yr after the 
completion of RT in ipsilateral and bilateral RT protocols. Patients were divided into 
lowest l/2 and highest l/2 groups based on pre-RT (baseline) UPFR. Bars with the 
same number indicate patients receiving similar amounts of radiation, while those with 
different numbers indicate patients receiving significantly different amounts of radia- 
tion. Groups with the same symbols (*,#) indicate significantly different (p < 0.05) 
flow rates. Results are expressed as mean f SEM. 
were statistically indistinguishable 
compared with baseline (p > 0.05); 
however, 1 yr post-RT UPFR from 
spared glands were significantly 
lower in patients from the bilateral 
protocol (p = 0.03). Similarly, SPFR 1 
yr post-RT in the spared glands from 
the ipsilateral protocol were statisti- 
cally indistinguishable compared 
with baseline (p > 0.05), and were 
significantly lower in patients from 
the bilateral protocol (p = 0.03). 
Furthermore, in the ipsilateral and 
bilateral protocols, UPFR and SPFR 
were not significantly different at 
baseline (p > 0.05) between the treat- 
ed and spared glands, but were sig- 
nificantly different 1 yr after RT (ipsi- 
lateral protocol-UPFR p = 0.0001, 
SPFR p = 0.02; bilateral protocol- 
UPFR p = 0.002, SPFR p = 0.0009). 
To determine which variables pro- 
vide protection against RT-induced 
SGD, patients in the ipsilateral and 
bilateral protocols were divided sepa- 
rately into two subgroups-highest 
1/2 and lowest 1/2-based on base- 
line UPFR and SPFR values from 
spared glands. For unstimulated sali- 
va, flow rates between the highest 1/2 
and lowest 1/2 groups were not sig- 
nificantly different 1 yr after the com- 
pletion of RT for patients in the ipsi- 
lateral and bilateral protocols (Fig. 1). 
For stimulated saliva, flow rates were 
also not significantly different 
between the highest 1/2 and lowest 
1/2 groups 1 yr after the completion 
of RT for patients in both ipsilateral 
and bilateral protocols (Fig. 2). 
To determine the influence of 
radiation doses on parotid function, 
subjects from both the ipsilateral and 
bilateral protocols were combined 
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Fig 2. Stimulated parotid flow rates (SPFR) at baseline (pre-RT) and 1 yr after the 
completion of RT in ipsilateral and bilateral RT protocols. Patients were divided into 
lowest l/2 and highest Y2groups based on pre-RT (baseline) SPFR. Bars with the 
same number indicate patients receiving similar amounts of radiation, while those 
with different numbers indicate patients receiving significantly different amounts of 
radiation. Groups with the same symbols (*,#,+) indicate significantly different (p < 
0.05) flow rates. Results are expressed as mean f SEM. 
Table 4. Radiation dose.a 
Radiation Dose Radiation Dose p Value 
Lowest 1/4 (n = 8) Highest 1/4 (n = 8) Lowest us. Highest 
UPFR~ 
Radiation dose (Gy) 
Baseline flow (mL/min) 
1-yr flow (mL/min) 
p value: Baseline us. 1 yr 
SPFR~ 
Radiation dose (Gy) 
Baseline flow (mL/min) 
1-yr flow (mL/min) 
p value: Baseline us. 1 yr 
2.0 t 0.8 
0.09 k 0.02 
0.07 c 0.02 
NS 
2.0 k 0.8 
0.52 c 0.12 
0.60 2 0.15 
NS 
22.0 c 10.0 0.0001 
0.09 t 0.03 NS' 
0.03 k 0.03 0.06 
0.03 
22.0 -+ 10.0 0.001 
0.35 c 0.20 NS 
0.16 k 0.04 0.01 
0.02 
a Results expressed as mean i SEM. 
Unstimulated parotid flow rate. 
Not statistically significant. 
Stimulated parotid flow rate. 
and placed into 2 groups based on 
radiation dose to spared parotid 
glands: highest 114 and lowest 114 
(Table 4). UPFR and SPFR were not 
significantly different at baseline. 
However, 1 yr after the completion of 
RT, flow rates were higher in the 
lowest 114 radiation group compared 
with the highest 114 radiation group 
(UPFR p = 0.06; SPFR p = 0.01). When 
comparisons were performed 
between UPFR and SPFR at baseline 
and 1 yr following the completion of 
RT within each radiation group, flow 
rates were not significantly different 
in the lowest 1/4 radiation group 
(UPFR p > 0.05; SPFR p > 0.05), but 
were significantly lower in the high- 
est 114 radiation group (UPFR p = 
0.03; SPFR p = 0.02). 
Discussion 
Head and neck RT for oral and pha- 
ryngeal cancers has a deleterious 
effect on salivary gland func- 
tion.4,5,12,14,16 There is a dose-response 
relationship between the amount of 
radiation delivered to oral tissues 
and the damage that eventually 
 occur.^.^,^^,^^ Radiation doses of 2100 
to 4000 cGy to tissues of the head and 
neck region have been shown to 
cause significant damage to salivary 
glands.12 The results of our previous 
studies have shown that through the 
use of 3-DTP, radiation dosages to 
contralateral parotid glands can be 
minimi~ed.~. '~ Patients requiring uni- 
lateral radiation received a mean of 
93% less radiation to spared glands, 
while patients receiving bilateral 
radiation received a mean of 65% less 
radiation to spared glands compared 
with treated parotid glands (Table 3).  
This reduction in radiation dose 
resulted in a partial preservation of 
contralateral parotid gland function, 
while nearly all output was lost in 
treated parotid glands. 
The majority of studies which 
have examined factors that influence 
the amount and severity of RT- 
induced SGD have been short-term 
investigations (< 3 mos). Several 
short-term studies reported that peo- 
ple with higher initial salivary flow 
rates required larger doses of radia- 
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tion to produce salivary hypofunc- 
t i ~ n . ~ , ' ~  These studies suggested that 
the dose-response relationship 
between SGD and RT is not linear, 
but is exponential, with the most 
severe SGD occurring during the 
early treatment periods of RT.8,13 It is 
possible that high baseline salivary 
flow rates may protect against SGD 
in the early stages of head and neck 
RT;*,13 however, after the accumula- 
tion of therapeutic doses of RT (usu- 
ally 2 60 Gy), all parotid gland func- 
tion is destroyed 6 to 12 mos follow- 
ing the completion of RT.20 
divided into two groups (highest 1/2 
and lowest 1/2, based on baseline 
UPFR and SPFR) to determine if high 
initial parotid gland flow rates pro- 
tected against RT-induced SGD. The 
results demonstrate that although 
patients in both groups had signifi- 
cantly different flow rates at baseline 
and received similar amounts of radi- 
ation, UPFR and SPFR were not sig- 
nificantly different 1 yr after the com- 
pletion of RT. In addition, in patients 
who received bilateral neck RT and 
had high initial salivary flow rates, 
there was a trend for both UPFR and 
SPFR to be lower 1 yr after the com- 
pletion of RT (Figs. 1,2). Therefore, 
the one-year results from the present 
study do not provide any evidence 
that high baseline UPFR or SPFR pro- 
vide protection against RT-induced 
SGD. 
of this study demonstrate that a sig- 
nificant relationship does exist 
between the amount of RT delivered 
to spared parotid glands and the 
extent of SGD. Previous studies have 
examined UPFR and SPFR and have 
showed that patients in the lowest 
radiation dose quartile (< 50 Gy) had 
significantly higher salivary flow 
rates compared with those in the 
highest dose quartile (> 68 GY) .~  In 
the present study, patients who 
underwent ipsilateral neck RT (mean 
dose of 3.6 Gy to contralateral parotid 
glands) had higher UPFR and SPFR 1 
yr after RT, compared with patients 
who received bilateral neck RT (mean 
dosage of 20.2 Gy to contralateral 
parotid glands). In addition, UPFR 
In the present study, patients were 
Alternatively, the one-year results 
and SPFR from spared glands in the 
bilateral protocol 1 yr after RT were 
significantly lower compared with 
baseline, while patients who received 
ipsilateral RT did not experience sig- 
nificant changes in parotid output 
from contralateral spared glands. 
These results have clinical impli- 
cations for the care of head and neck 
cancer patients receiving RT. A sig- 
nificant predictor for RT-induced 
SGD could identify patients who may 
be vulnerable to the detrimental side- 
effects of RT. This would allow clini- 
cians the ability to initiate special pre- 
ventive measures to help decrease 
morbidity from RT-induced oral and 
pharyngeal complications.6,21 The 
results of this study suggest that the 
amount of radiation delivered to con- 
tralateral parotid glands should be 
minimized as much as possible, de- 
pending on the cancer stage, so that 
some parotid salivary gland function 
can be spared. Since saliva plays a 
central role in maintaining oral and 
pharyngeal health, this would help 
preserve oral function and a person's 
quality of life in patients following 
the completion of RT. 
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